<DOC>
	<DOC>NCT01137084</DOC>
	<brief_summary>The purpose of this study was to evaluate the safety and efficacy of a steroid-free immunosuppression protocol in Hepatocellular Carcinoma (HCC) patients.</brief_summary>
	<brief_title>Liver Transplantation Results in Hepatocellular Carcinoma Patients With Immunosuppression Without Steroids</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Carcinoma, Hepatocellular</mesh_term>
	<mesh_term>Postoperative Complications</mesh_term>
	<mesh_term>Methylprednisolone Hemisuccinate</mesh_term>
	<criteria>All liver transplantation patients with hepatocellular carcinoma in our center between Jan 2005 and Dec 2009 were potentially eligible for enrollment the recipient pass away within 3 month following up liver transplantation Inability to provide written informed consent prior to study entry acute rejection are treated only with steroids</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2010</verification_date>
</DOC>